PFA
LCTX icon

Paradigm Financial Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Paradigm Financial Advisors’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-17,100
Closed -$17K – 134
2019
Q3 		$17K Hold
17,100
– – 0.01% 126
2019
Q2 		$19K Hold
17,100
– – 0.01% 130
2019
Q1 		$22K Buy
17,100
+7,100
+71% +$8.83K 0.01% 123
2018
Q4 		$9K Sell
10,000
-1,430
-13% -$2.19K ﹤0.01% 128
2018
Q3 		$23K Buy
+11,430
New +$24K 0.01% 132

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return